Enhertu Shows Promise as Early-Stage Breast Cancer Treatment, Raising Hopes for Higher Cure Rates Berlin – Landmark data unveiled Saturday at the European Society for Medical Oncology (ESMO) annual conference signals a potential paradigm shift in breast cancer treatment. Enhertu, already a vital therapy for advanced disease, demonstrates significant benefits when administered earlier in the … Read more
The biopharmaceutical industry continues to experience a dynamic shift in leadership, with key personnel changes signaling strategic realignments and growth initiatives. Today, Dispatch Bio announced the appointment of Mauro Avanzi as its new Chief Medical Officer, a pivotal role for the rapidly expanding biotechnology firm. Avanzi brings a wealth of experience to Dispatch Bio, having … Read more
Expedition Therapeutics Secures $165 Million to Advance COPD Drug Development In a significant boost for respiratory medicine, Expedition Therapeutics has announced the successful completion of a $165 million Series A funding round. The financing will propel the company’s lead drug candidate, a novel treatment for chronic obstructive pulmonary disease (COPD), into its first clinical trial. … Read more
Colorado Sets National Precedent with Enbrel Price Cap, Sparking Drug Cost Debate Denver, Colorado – In a groundbreaking decision poised to reshape the landscape of prescription drug pricing, a Colorado state panel has voted to impose an upper payment limit on Enbrel, a widely used medication for arthritis and other autoimmune conditions. This first-in-the-nation move … Read more